NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HUYA Bioscience International

HUYA Bioscience International

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://huyabio.com/

Last Round

Debt

May 3, 2020

Total Funding Raised

$53M

Company Overview

HUYA Bioscience International is a biopharmaceutical company that identifies, develops, and commercializes innovative drug candidates originating in China for global markets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug in-licensingbiopharmaceutical developmentpharma licensingclinical developmentoncology drug developmentdrug commercializationbiotech licensingcardiovascular drug developmentdrug discoverypharma bridgeregulatory approvalco-developmentdrug pipelineasset globalizationbiotech incubator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HUYA Bioscience International Comparables

Compare HUYA Bioscience International with similar companies based on industry and business-model similarity.

HUYA Bioscience International comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xynomic Pharmaceuticals
80%
ArriVent
78%
Boston Pharmaceuticals
77%

HUYA Bioscience International Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 3, 2020
Series BApr 22, 2015
VC RoundApr 2, 2012
SeedApr 7, 2009
Corporate FundingJan 9, 2007

Key People

Founding team and executive leadership

Jason Wang

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 21, 2024

    Monthly visitors increased 462% MoM, from 1.3K to 7.3K.

  • Apr 22, 2015

    $48M round completed.

HUYA Bioscience International Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HUYA Bioscience International Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HUYA Bioscience International's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range127
Year Founded2004
Last FundingMay 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.